EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis

Overview of attention for article published in International Journal of Nanomedicine, April 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E–/– Mice

Article in ACS Omega (August 2022)

Recent advances on nanoparticle-based therapies for cardiovascular diseases

Article in Journal of Cardiology (February 2022)

Chapter 8 Combating atherosclerosis with nanodrug delivery approaches: from bench side to commercialization

Book chapter (January 2022)